CACH/VWM syndrome and leucodystrophies related to EIF2B mutations (Orphanet)

被引:7
作者
Labauge, P. [1 ]
Fogli, A.
Niel, F.
Rodriguez, D.
Boespflug-Tanguy, O.
机构
[1] Hop Caremeau, CHU Montpellier Nimes, Serv Neurol, F-30029 Nimes, France
[2] Univ Auvergne, INSERM, UMR 384, Fac Med, Clermont Ferrand, France
[3] CHU, UF Biol Mol, Serv Biochim Med, Lab Reference Leucodystrophies, Clermont Ferrand, France
[4] Hop Armand Trousseau, AP HP, Serv Neuropediat, Paris, France
[5] Univ Paris 06, INSERM, U546, Paris, France
[6] CHU Clermont Ferrand, Serv Genet Med, Ctr Reference Leucodystrophies, F-63003 Clermont Ferrand, France
关键词
CACH; VWM; orthochromatic leukodystrophy; cree leukoencephalopathy; ovarioleukodystrophy; elF2B;
D O I
10.1016/S0035-3787(07)91461-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A new leukoencephatopathy, the CACH syndrome (Childhood Ataxia with Central nervous system Hypomyelination) or VWM (Vanishing White Matter) was identified on clinical and MRI criteria. Classically, this disease is characterized by (1) an onset between 2 and 5 years of age, with a cerebello-spastic syndrome exacerbated by episodes of fever or head trauma leading to death after 5 to 10 years of disease evolution, (2) a diffuse involvement of the white matter on cerebral MRI with a CSF-like signal intensity (cavitation), (3) a recessive autosomal mode of inheritance, (4) neuropathologic findings consistent with a cavitating orthochromatic leukodystrophy with increased number of oligodendrocytes with sometimes 'foamy" aspect. A total of 148 cases have been reported so far. This disease is linked to mutations in the five EIF2B genes encoding the five subunits of the eukaryotic initiation factor 2B (elF2B), involved in the protein synthesis and its regulation under cellular stresses. Clinical symptoms are variable, from fatale infantile forms (Cree leukoencephalopathy) and congenital forms associated with extra-neurological affections, to juvenile and adult forms (ovarioleukodystrophy) characterized by cognitive and behaviour dysfunctions and by a slow progression of the disease, leading to the term of elF2B-related leukoencephalopathies. Prevalence of these remains unknown. Diagnosis lays on the detection of EIF2B mutations, affecting predominantly the EIF2B5 gene. A decrease in the intrinsic activity of the elF2B factor (the guanine exchange activity, GEF) in lymphoblasts from patients seems to have a diagnostic value. The patho-physiology of the disease would involve a deficiency in astrocytes maturation leading to an increased susceptibility of the white matter to cellular stress. No specific treatment exists except the 'Prevention" of cellular stress. Corticosteroids sometimes proved to be useful in acute phases. Prognosis seems to correlate with the age of onset, the earliest forms being more severe.
引用
收藏
页码:793 / 799
页数:7
相关论文
共 35 条
[1]   Leukoencephalopathy with vanishing white matter: An adult onset case [J].
Biancheri, R ;
Rossi, A ;
Di Rocco, M ;
Filocamo, M ;
Pronk, JC ;
van der Knaap, MS ;
Tortori-Donati, P .
NEUROLOGY, 2003, 61 (12) :1818-1819
[2]   LEUKOENCEPHALOPATHY AMONG NATIVE INDIAN INFANTS IN NORTHERN QUEBEC AND MANITOBA [J].
BLACK, DN ;
BOOTH, F ;
WATTERS, GV ;
ANDERMANN, E ;
DUMONT, C ;
HALLIDAY, WC ;
HOOGSTRATEN, J ;
KABAY, ME ;
KAPLAN, P ;
MEAGHERVILLEMURE, K ;
MICHAUD, J ;
OGORMAN, G .
ANNALS OF NEUROLOGY, 1988, 24 (04) :490-496
[3]   Membrane phospholipids and high-energy metabolites in childhood ataxia with CNS hypomyelination [J].
Blüml, S ;
Philippart, M ;
Schiffmann, R ;
Seymour, K ;
Ross, BD .
NEUROLOGY, 2003, 61 (05) :648-654
[4]   EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy [J].
Dietrich, J ;
Lacagnina, M ;
Gass, D ;
Richfield, E ;
Mayer-Pröschel, M ;
Noble, M ;
Torres, C ;
Pröschel, C .
NATURE MEDICINE, 2005, 11 (03) :277-283
[5]   Peripheral neuropathy in vanishing white matter disease with a novel EIF2B5 mutation [J].
Federico, A. ;
Scali, O. ;
Stromillo, M. L. ;
Di Perri, C. ;
Bianchi, S. ;
Sicurelli, F. ;
De Stefano, N. ;
Malandrini, A. ;
Dotti, M. T. .
NEUROLOGY, 2006, 67 (02) :353-355
[6]   The effect of genotype on the natural history of eIF2B-related leukodystrophies [J].
Fogli, A ;
Schiffmann, R ;
Bertini, E ;
Ughetto, S ;
Combes, P ;
Eymard-Pierre, E ;
Kaneski, CR ;
Pineda, M ;
Troncoso, M ;
Uziel, G ;
Surtees, R ;
Pugin, D ;
Chaunu, MP ;
Rodriguez, D ;
Boespflug-Tanguy, O .
NEUROLOGY, 2004, 62 (09) :1509-1517
[7]   The large spectrum of eIF2B-related diseases [J].
Fogli, A ;
Boespflug-Tanguy, O .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 :22-29
[8]   Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients [J].
Fogli, A ;
Schiffmann, R ;
Hugendubler, L ;
Combes, P ;
Bertini, E ;
Rodriguez, D ;
Kimball, SR ;
Boespflug-Tanguy, O .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2004, 12 (07) :561-566
[9]   Ovarian failure related to eukaryotic initiation factor 2B mutations [J].
Fogli, A ;
Rodriguez, D ;
Eymard-Pierre, E ;
Bouhour, F ;
Labauge, P ;
Meaney, BF ;
Zeesman, S ;
Kaneski, CR ;
Schiffmann, R ;
Boespflug-Tanguy, O .
AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 72 (06) :1544-1550
[10]   A severe variant of childhood ataxia with central hypomyelination/vanishing white matter leukoencephalopathy related to EIF21B5 mutation [J].
Fogli, A ;
Dionisi-Vici, C ;
Deodato, F ;
Bartuli, A ;
Boespflug-Tanguy, O ;
Bertini, E .
NEUROLOGY, 2002, 59 (12) :1966-1968